DOCOSANOL

DOCOSANOL was reported 14600 times

DOCOSANOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACRIMAL DUCT PIGMENTATION 1 0.3333
1 APPLICATION SITE BLEEDING 45 0.1822
2 OCHLOPHOBIA 1 0.1429
3 ORAL HERPES 2458 0.1258
4 APPLICATION SITE ANAESTHESIA 8 0.1143
5 ERYTHROPOIETIN DEFICIENCY ANAEMIA 1 0.1111
6 HERPES SIMPLEX 706 0.1085
7 ORAL MUCOSAL SCAR 2 0.0909
8 APPLICATION SITE HYPOAESTHESIA 19 0.0812
9 APPLICATION SITE SCAR 101 0.0807
10 APPLICATION SITE SCAB 165 0.0763
11 PIGMENTATION LIP 8 0.0741
12 APPLICATION SITE HYPERAESTHESIA 7 0.0707
13 LIP HAEMORRHAGE 87 0.0682
14 APPLICATION SITE PARAESTHESIA 87 0.0667
15 APPLICATION SITE INFECTION 33 0.0648
16 DRUG ADMINISTRATION ERROR 1779 0.0579
17 LIP INFECTION 12 0.0566
18 LIP PAIN 153 0.0533
19 LIP SCAB 5 0.0515
20 APPLICATION SITE SWELLING 208 0.0417
21 APPLICATION SITE INDURATION 7 0.0412
22 LIP EXFOLIATION 50 0.0376
23 LIP ERYTHEMA 28 0.0350
24 LIP BLISTER 92 0.0337
25 APPLICATION SITE HAEMORRHAGE 89 0.0326
26 LIP DISORDER 59 0.0311
27 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 11 0.0303
28 APPLICATION SITE PALLOR 1 0.0303
29 LIP DISCOLOURATION 38 0.0301
30 INCORRECT PRODUCT ADMINISTRATION DURATION 642 0.0296
31 INCORRECT DRUG ADMINISTRATION DURATION 803 0.0285
32 CHEILITIS 146 0.0270
33 LIP PRURITUS 22 0.0257
34 CHAPPED LIPS 104 0.0239
35 INTRANASAL HYPOAESTHESIA 2 0.0213
36 REST REGIMEN 1 0.0208
37 PRODUCT PACKAGE ASSOCIATED INJURY 46 0.0206
38 HERNIA PERFORATION 2 0.0204
39 APPLICATION SITE PAIN 448 0.0203
40 APPLICATION SITE DRYNESS 68 0.0200
41 APPLICATION SITE DISCOLOURATION 81 0.0199
42 FUNCTIONAL RESIDUAL CAPACITY DECREASED 1 0.0196
43 APPLICATION SITE IRRITATION 232 0.0186
44 APPLICATION SITE DISCHARGE 21 0.0182
45 APPLICATION SITE REACTION 123 0.0175
46 LIP SWELLING 560 0.0168
47 APPLICATION SITE EXCORIATION 1 0.0154
48 BRONCHOMALACIA 2 0.0152
49 PRODUCT COMPLAINT 374 0.0147
50 LIP DRY 126 0.0139
51 APPLICATION SITE INFLAMMATION 19 0.0137
52 APPLICATION SITE VESICLES 87 0.0134
53 NERVE ROOT INJURY 1 0.0132
54 THERAPEUTIC PRODUCT EFFECT DELAYED 58 0.0127
55 ALPHA-1 ANTI-TRYPSIN DEFICIENCY 1 0.0127
56 APPLICATION SITE PAPULES 13 0.0123
57 APPLICATION SITE WOUND 2 0.0121
58 ORAL DISCOMFORT 167 0.0120
59 APPLICATION SITE PUSTULES 4 0.0110
60 ALCOHOL TEST FALSE POSITIVE 1 0.0106
61 APPLICATION SITE INJURY 2 0.0105
62 BACTERIA URINE 1 0.0104
63 APPLICATION SITE EROSION 13 0.0101
64 APPLICATION SITE ULCER 7 0.0099
65 PHARYNGOLARYNGEAL DISCOMFORT 1 0.0097
66 APPLICATION SITE LACERATION 4 0.0097
67 BLISTER RUPTURE 7 0.0094
68 APPLICATION SITE ERYTHEMA 246 0.0094
69 APPLICATION SITE BURN 46 0.0093
70 DRUG EFFECT FASTER THAN EXPECTED 3 0.0090
71 APPLICATION SITE EXFOLIATION 37 0.0090
72 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
73 APPLICATION SITE DISCOMFORT 16 0.0089
74 EMERGENCY CARE EXAMINATION 6 0.0088
75 NO ADVERSE DRUG EFFECT 6 0.0088
76 APPLICATION SITE WARMTH 11 0.0086
77 INFUSION SITE SCAB 1 0.0081
78 CIRCUMORAL SWELLING 1 0.0078
79 SCAB 84 0.0074
80 INTENTIONAL DRUG MISUSE 151 0.0072
81 ADMINISTRATION SITE IRRITATION 1 0.0071
82 PENILE BURNING SENSATION 2 0.0070
83 BUCCAL MUCOSAL ROUGHENING 1 0.0070
84 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 493 0.0069
85 LIP INJURY 9 0.0069
86 DRUG EFFECT DELAYED 30 0.0066
87 DIAGNOSTIC PROCEDURE 1 0.0066
88 CONDITION AGGRAVATED 1967 0.0065
89 HAEMORRHAGIC DIATHESIS 23 0.0065
90 ENDOMETRIAL CANCER METASTATIC 1 0.0062
91 LARYNGOMALACIA 2 0.0060
92 APPLICATION SITE PERSPIRATION 1 0.0058
93 PRODUCT PACKAGING DIFFICULT TO OPEN 15 0.0057
94 MILIA 2 0.0055
95 EXAGGERATED STARTLE RESPONSE 1 0.0055
96 THERAPEUTIC PRODUCT EFFECT VARIABLE 21 0.0054
97 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0054
98 DRUG INEFFECTIVE 7071 0.0054
99 HYPOAESTHESIA FACIAL 8 0.0053
100 GINGIVAL INFLAMMATION 1 0.0053
101 NONSPECIFIC REACTION 29 0.0053
102 EXPIRED PRODUCT ADMINISTERED 175 0.0053
103 DYSPHORIA 26 0.0051
104 GINGIVAL ATROPHY 1 0.0051
105 IMPLANT SITE MASS 1 0.0051
106 TRACHEOMALACIA 2 0.0051
107 ARTHRITIS INFECTIVE 22 0.0047
108 PERIORAL DERMATITIS 3 0.0047
109 SCAR 80 0.0047
110 OEDEMA MOUTH 15 0.0046
111 DRUG EFFECT LESS THAN EXPECTED 67 0.0045
112 PARAESTHESIA ORAL 65 0.0045
113 SWELLING FACE 288 0.0044
114 MALABSORPTION FROM ADMINISTRATION SITE 1 0.0043
115 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 125 0.0043
116 GASTROSCHISIS 2 0.0042
117 INJECTION SITE NERVE DAMAGE 1 0.0042
118 HYPOAESTHESIA ORAL 63 0.0042
119 MOLE EXCISION 1 0.0041
120 SKIN LACERATION 44 0.0040
121 EXPIRED DRUG ADMINISTERED 20 0.0040
122 MOUTH SWELLING 23 0.0040
123 PRODUCT QUALITY ISSUE 539 0.0040
124 APPETITE DISORDER 26 0.0039
125 APPLICATION SITE PRURITUS 87 0.0038
126 HERPES ZOSTER REACTIVATION 1 0.0038
127 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 70 0.0038
128 SKIN WARM 22 0.0038
129 EXOMPHALOS 2 0.0037
130 INTENTIONAL MISUSE 7 0.0037
131 PRODUCT PHYSICAL CONSISTENCY ISSUE 20 0.0036
132 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
133 DRUG EFFECT VARIABLE 4 0.0035
134 GRUNTING 2 0.0033
135 AURICULAR SWELLING 2 0.0033
136 PERSISTENT FOETAL CIRCULATION 2 0.0033
137 APPLICATION SITE DERMATITIS 3 0.0032
138 DRUG ADMINISTERED AT INAPPROPRIATE SITE 32 0.0030
139 ORAL MUCOSAL DISCOLOURATION 2 0.0030
140 IODINE ALLERGY 1 0.0030
141 CIRCUMORAL OEDEMA 1 0.0029
142 RADIAL NERVE PALSY 1 0.0028
143 BURNING SENSATION MUCOSAL 1 0.0028
144 ORAL DISCHARGE 1 0.0027
145 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 552 0.0027
146 SALIVARY GLAND CALCULUS 1 0.0027
147 BLUNTED AFFECT 2 0.0027
148 CHEMICAL BURN 3 0.0026
149 LIP OEDEMA 11 0.0026
150 BREAST FEEDING 2 0.0026
151 LUNG CYST 1 0.0025
152 ORAL PAIN 57 0.0025
153 BRONCHOPULMONARY DYSPLASIA 2 0.0025
154 TONGUE ERYTHEMA 2 0.0024
155 TENDERNESS 25 0.0024
156 CORNEAL DYSTROPHY 1 0.0024
157 PSEUDOMONAL BACTERAEMIA 2 0.0023
158 TONGUE PRURITUS 2 0.0023
159 GINGIVAL ERYTHEMA 2 0.0023
160 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 404 0.0022
161 FACIAL PAIN 20 0.0022
162 ENLARGED UVULA 1 0.0022
163 CAECITIS 1 0.0022
164 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
165 NASAL OEDEMA 4 0.0022
166 BIOPSY BONE MARROW ABNORMAL 1 0.0022
167 INCISION SITE ERYTHEMA 1 0.0022
168 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
169 BLISTER 118 0.0021
170 VASCULAR INJURY 3 0.0021
171 BLOOD CREATINE ABNORMAL 1 0.0021
172 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0021
173 ENCEPHALITIS HERPES 1 0.0020
174 LEUKOPLAKIA ORAL 1 0.0019
175 BLADDER OBSTRUCTION 1 0.0019
176 POLYOMAVIRUS VIRAEMIA 2 0.0019
177 GINGIVAL DISCOLOURATION 1 0.0019
178 BLOOD GASES ABNORMAL 1 0.0019
179 MARITAL PROBLEM 1 0.0018
180 THERMAL BURN 13 0.0018
181 APPLICATION SITE RASH 25 0.0018
182 MILK ALLERGY 1 0.0018
183 BONE FRAGMENTATION 1 0.0018
184 SKIN WOUND 3 0.0018
185 LIFE EXPECTANCY SHORTENED 1 0.0018
186 HYPERSENSITIVITY 319 0.0017
187 PRURITUS ALLERGIC 2 0.0017
188 LIP ULCERATION 2 0.0017
189 AMBLYOPIA 1 0.0017
190 INDURATION 3 0.0017
191 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0017
192 ENDOSCOPY 1 0.0017
193 SUSPECTED PRODUCT QUALITY ISSUE 3 0.0016
194 INFUSION SITE WARMTH 2 0.0016
195 BLOOD BLISTER 5 0.0016
196 MONOCLONAL GAMMOPATHY 1 0.0016
197 NASAL PRURITUS 2 0.0016
198 MUCOSAL DISCOLOURATION 1 0.0016
199 CHANGE IN SEIZURE PRESENTATION 1 0.0015
200 ALLERGIC OEDEMA 1 0.0015
201 EAR PAIN 30 0.0015
202 NASAL CRUSTING 1 0.0015
203 CHONDROCALCINOSIS 1 0.0015
204 PHARYNGEAL ULCERATION 2 0.0015
205 ADVERSE REACTION 20 0.0015
206 PHOTOPHOBIA 28 0.0015
207 BURNING SENSATION 104 0.0015
208 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
209 ANGULAR CHEILITIS 1 0.0014
210 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
211 FACIAL PALSY 3 0.0014
212 WOUND HAEMORRHAGE 5 0.0014
213 THINKING ABNORMAL 25 0.0013
214 ORAL MUCOSAL EXFOLIATION 2 0.0013
215 MOUTH INJURY 2 0.0013
216 ORAL PRURITUS 3 0.0013
217 APHTHOUS STOMATITIS 3 0.0013
218 BLISTER INFECTED 1 0.0013
219 PLACENTA PRAEVIA 1 0.0013
220 EYELID FUNCTION DISORDER 1 0.0013
221 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 68 0.0012
222 POST-TRAUMATIC NECK SYNDROME 1 0.0012
223 ORAL DISORDER 9 0.0012
224 CHEMICAL INJURY 1 0.0012
225 INTENTIONAL DEVICE USE ISSUE 1 0.0012
226 PURULENT DISCHARGE 5 0.0012
227 CERVICAL SPINAL STENOSIS 2 0.0012
228 DEVICE LOOSENING 1 0.0012
229 GENITAL BURNING SENSATION 1 0.0012
230 INFUSION SITE DISCOLOURATION 1 0.0011
231 GINGIVAL SWELLING 5 0.0011
232 SKIN HYPOPIGMENTATION 2 0.0011
233 ANOGENITAL WARTS 1 0.0011
234 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
235 SALIVA ALTERED 1 0.0011
236 PRODUCT USE ISSUE 208 0.0011
237 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
238 LOCAL SWELLING 19 0.0011
239 PNEUMONIA KLEBSIELLA 2 0.0011
240 BIOPSY 1 0.0011
241 INTERCEPTED MEDICATION ERROR 5 0.0011
242 AURA 2 0.0011
243 NASAL OBSTRUCTION 2 0.0011
244 LACERATION 10 0.0011
245 WOUND 29 0.0010
246 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
247 APPLICATION SITE BRUISE 1 0.0010
248 SNEEZING 23 0.0010
249 PRODUCT USE IN UNAPPROVED INDICATION 254 0.0010
250 SKIN INDURATION 2 0.0010
251 AXILLARY MASS 1 0.0010
252 OEDEMA MUCOSAL 1 0.0010
253 DEVICE CONNECTION ISSUE 2 0.0009
254 IMPAIRED HEALING 31 0.0009
255 GALLBLADDER ENLARGEMENT 1 0.0009
256 IRON OVERLOAD 1 0.0009
257 PILOERECTION 1 0.0009
258 CORNEAL DISORDER 2 0.0009
259 EXPIRED DEVICE USED 3 0.0009
260 ACCIDENTAL EXPOSURE TO PRODUCT 93 0.0009
261 TONGUE BLISTERING 2 0.0009
262 OPEN WOUND 1 0.0009
263 THERAPEUTIC RESPONSE UNEXPECTED 40 0.0009
264 PHARMACEUTICAL PRODUCT COMPLAINT 23 0.0009
265 VIITH NERVE PARALYSIS 3 0.0009
266 ADMINISTRATION SITE PAIN 1 0.0009
267 ESCHERICHIA BACTERAEMIA 2 0.0008
268 GLOSSITIS 3 0.0008
269 BLEEDING TIME PROLONGED 1 0.0008
270 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
271 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
272 TENSION 5 0.0008
273 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
274 BREECH PRESENTATION 1 0.0008
275 OSTEITIS 2 0.0008
276 SKIN DISORDER 26 0.0008
277 DACRYOSTENOSIS ACQUIRED 1 0.0008
278 APHTHOUS ULCER 6 0.0008
279 ORAL INFECTION 3 0.0008
280 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54 0.0008
281 PHARYNGOLARYNGEAL PAIN 4 0.0008
282 PRODUCT DELIVERY MECHANISM ISSUE 4 0.0007
283 BODY MASS INDEX INCREASED 1 0.0007
284 CARBON DIOXIDE INCREASED 1 0.0007
285 DRUG EFFECT INCOMPLETE 26 0.0007
286 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
287 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
288 CULTURE URINE POSITIVE 1 0.0007
289 CHORIORETINOPATHY 1 0.0007
290 GENITAL RASH 1 0.0007
291 ABNORMAL SENSATION IN EYE 3 0.0007
292 HERPES VIRUS INFECTION 4 0.0007
293 NONINFECTIVE GINGIVITIS 1 0.0007
294 INTESTINAL OBSTRUCTION 26 0.0007
295 NAIL DISORDER 6 0.0007
296 PULMONARY PAIN 2 0.0007
297 TOOTH DISCOLOURATION 2 0.0007
298 STRIDOR 2 0.0007
299 GENITAL PAIN 1 0.0007
300 CONJUNCTIVITIS ALLERGIC 1 0.0007
301 AXILLARY PAIN 1 0.0007
302 IMPETIGO 1 0.0007
303 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
304 HEAT STROKE 1 0.0007
305 ORAL MUCOSAL ERUPTION 1 0.0007
306 CALCULUS URINARY 1 0.0006
307 PREMATURE SEPARATION OF PLACENTA 1 0.0006
308 DAYDREAMING 1 0.0006
309 MEAN CELL VOLUME DECREASED 1 0.0006
310 ORAL MUCOSAL ERYTHEMA 1 0.0006
311 EYE ALLERGY 1 0.0006
312 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
313 BACTERIAL VAGINOSIS 1 0.0006
314 PHARYNGEAL PARAESTHESIA 1 0.0006
315 MEDICATION RESIDUE PRESENT 3 0.0006
316 GINGIVAL PAIN 5 0.0006
317 NASAL ULCER 1 0.0006
318 SUBCUTANEOUS ABSCESS 3 0.0006
319 EYE SWELLING 23 0.0006
320 BACTERIAL SEPSIS 2 0.0006
321 INCORRECT DOSAGE ADMINISTERED 3 0.0006
322 OSTEOARTHRITIS 26 0.0006
323 ERYTHEMA 126 0.0006
324 HYPERAESTHESIA 5 0.0006
325 SWOLLEN TONGUE 19 0.0006
326 INFUSION SITE HAEMORRHAGE 2 0.0006
327 EXPOSURE DURING BREAST FEEDING 2 0.0006
328 SKIN INJURY 2 0.0006
329 ARTHROPOD STING 1 0.0006
330 DRUG TOLERANCE 3 0.0006
331 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
332 MILIARIA 1 0.0006
333 FIXED ERUPTION 1 0.0006
334 PRODUCT COUNTERFEIT 1 0.0006
335 INFUSION SITE DISCHARGE 1 0.0006
336 EAR PRURITUS 2 0.0006
337 IMPRISONMENT 1 0.0006
338 FEAR OF DISEASE 1 0.0006
339 PRODUCT TAMPERING 1 0.0006
340 RHINORRHOEA 36 0.0006
341 PRODUCT RESIDUE PRESENT 3 0.0006
342 OBSESSIVE THOUGHTS 1 0.0006
343 ESSENTIAL HYPERTENSION 1 0.0005
344 MOUTH HAEMORRHAGE 4 0.0005
345 INFUSION SITE PAIN 7 0.0005
346 CYSTIC FIBROSIS 3 0.0005
347 LYMPH NODE PAIN 1 0.0005
348 PRODUCT PACKAGING ISSUE 5 0.0005
349 MOTION SICKNESS 1 0.0005
350 INTERSTITIAL LUNG DISEASE 25 0.0005
351 ILL-DEFINED DISORDER 31 0.0005
352 ANAPHYLACTIC REACTION 28 0.0005
353 PATENT DUCTUS ARTERIOSUS 2 0.0005
354 NECK PAIN 28 0.0005
355 OBSTRUCTION 2 0.0005
356 SENSORY DISTURBANCE 8 0.0005
357 NIPPLE PAIN 1 0.0005
358 EMBOLISM 4 0.0005
359 SWELLING 45 0.0005
360 ACCIDENTAL EXPOSURE 2 0.0005
361 LYMPHADENOPATHY 17 0.0005
362 PHYSICAL ASSAULT 1 0.0005
363 SWELLING OF EYELID 3 0.0005
364 EAR SWELLING 1 0.0005
365 TONGUE DISCOMFORT 2 0.0005
366 PRODUCT DISPENSING ISSUE 2 0.0005
367 SKIN ULCER 12 0.0005
368 INFUSION SITE BRUISING 1 0.0005
369 OEDEMA 25 0.0005
370 CERVICAL DYSPLASIA 1 0.0005
371 LIMB MASS 1 0.0005
372 WHEEZING 27 0.0005
373 PHARYNGEAL OEDEMA 7 0.0005
374 COLONOSCOPY 1 0.0005
375 MIDDLE EAR EFFUSION 1 0.0005
376 GASTROINTESTINAL ULCER 1 0.0005
377 PRODUCT LOT NUMBER ISSUE 1 0.0005
378 ADENOCARCINOMA 1 0.0004
379 APPLICATION SITE URTICARIA 1 0.0004
380 RENAL COLIC 1 0.0004
381 EYELID DISORDER 1 0.0004
382 INFUSION SITE INFECTION 1 0.0004
383 STOMATITIS 26 0.0004
384 SKIN TIGHTNESS 2 0.0004
385 PRURITUS GENITAL 1 0.0004
386 ADVERSE DRUG REACTION 38 0.0004
387 EATING DISORDER 9 0.0004
388 PUSTULE 1 0.0004
389 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
390 EXPOSURE DURING PREGNANCY 26 0.0004
391 SKIN IRRITATION 19 0.0004
392 LYMPHADENITIS 1 0.0004
393 SKIN FISSURES 8 0.0004
394 PARAESTHESIA 64 0.0004
395 CARTILAGE INJURY 1 0.0004
396 HYPERVOLAEMIA 2 0.0004
397 INSTILLATION SITE PAIN 1 0.0004
398 SUNBURN 3 0.0004
399 HYPOAESTHESIA 60 0.0004
400 RASH MACULAR 14 0.0004
401 HYPERPARATHYROIDISM SECONDARY 1 0.0004
402 LABYRINTHITIS 1 0.0004
403 BRAIN ABSCESS 1 0.0004
404 EXCORIATION 1 0.0004
405 INCREASED UPPER AIRWAY SECRETION 2 0.0004
406 MEDICATION RESIDUE 1 0.0004
407 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
408 TOOTHACHE 7 0.0004
409 FURUNCLE 3 0.0004
410 ANIMAL BITE 1 0.0004
411 ANGIONEUROTIC OEDEMA 1 0.0004
412 GINGIVITIS 2 0.0004
413 CHONDROPATHY 1 0.0004
414 ADVERSE EVENT 34 0.0004
415 ORAL FUNGAL INFECTION 1 0.0004
416 RASH 157 0.0004
417 HEART RATE ABNORMAL 2 0.0004
418 HALLUCINATION 27 0.0004
419 LUNG CONSOLIDATION 1 0.0004
420 INFUSION SITE ERYTHEMA 3 0.0004
421 FACE OEDEMA 6 0.0004
422 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
423 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
424 PERIORBITAL SWELLING 2 0.0004
425 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
426 JOINT LOCK 1 0.0004
427 PRODUCT CONTAINER ISSUE 3 0.0003
428 VENTRICULAR SEPTAL DEFECT 2 0.0003
429 SKIN HAEMORRHAGE 5 0.0003
430 OCULAR HYPERAEMIA 16 0.0003
431 PLEURISY 2 0.0003
432 SYMPTOM RECURRENCE 2 0.0003
433 MOUTH ULCERATION 7 0.0003
434 PALLOR 9 0.0003
435 EMERGENCY CARE 1 0.0003
436 EYE INJURY 1 0.0003
437 KERATITIS 1 0.0003
438 MASTICATION DISORDER 1 0.0003
439 SPEECH DISORDER 17 0.0003
440 EYELIDS PRURITUS 1 0.0003
441 INFUSION SITE SWELLING 2 0.0003
442 PAIN IN JAW 9 0.0003
443 DYSPHAGIA 30 0.0003
444 GLOSSODYNIA 7 0.0003
445 MUSCLE TIGHTNESS 5 0.0003
446 PRURITUS 117 0.0003
447 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
448 POTENTIATING DRUG INTERACTION 1 0.0003
449 DRUG EFFECT DECREASED 16 0.0003
450 MUSCULOSKELETAL STIFFNESS 26 0.0003
451 NEOPLASM RECURRENCE 1 0.0003
452 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
453 PUSTULAR PSORIASIS 1 0.0003
454 CONTUSION 28 0.0003
455 EYE DISCHARGE 3 0.0003
456 MEDICATION ERROR 16 0.0003
457 DERMATITIS 6 0.0003
458 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
459 SKIN DISCOLOURATION 13 0.0003
460 LUNG TRANSPLANT 1 0.0003
461 CHILLS 33 0.0003
462 FIBRIN D DIMER INCREASED 1 0.0003
463 DRUG INTOLERANCE 27 0.0003
464 FRUSTRATION 1 0.0003
465 POOR QUALITY SLEEP 6 0.0003
466 PRURITUS GENERALISED 6 0.0003
467 BONE LESION 1 0.0003
468 DRY SKIN 37 0.0003
469 RENAL TRANSPLANT 1 0.0003
470 PARADOXICAL DRUG REACTION 1 0.0003
471 OCULAR DISCOMFORT 3 0.0003
472 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
473 PARANASAL SINUS DISCOMFORT 1 0.0003
474 DERMATITIS CONTACT 3 0.0003
475 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
476 PROCEDURAL COMPLICATION 2 0.0003
477 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
478 APNOEA 2 0.0003
479 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
480 NAIL DISCOLOURATION 1 0.0003
481 OESOPHAGEAL PAIN 1 0.0003
482 NASAL DISCOMFORT 2 0.0003
483 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
484 CANDIDIASIS 1 0.0002
485 EYE PAIN 14 0.0002
486 PRODUCT ADMINISTRATION ERROR 5 0.0002
487 RHEUMATOID ARTHRITIS 28 0.0002
488 FEEDING DISORDER 5 0.0002
489 URTICARIA 41 0.0002
490 EYE IRRITATION 14 0.0002
491 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
492 ATRIAL SEPTAL DEFECT 2 0.0002
493 SENSATION OF FOREIGN BODY 2 0.0002
494 CARDIAC FAILURE CHRONIC 1 0.0002
495 ALCOHOLISM 1 0.0002
496 DEVICE OPERATIONAL ISSUE 1 0.0002
497 HORDEOLUM 1 0.0002
498 MONOPLEGIA 1 0.0002
499 MELANOCYTIC NAEVUS 1 0.0002
500 DYSPHEMIA 1 0.0002
501 ONYCHOMYCOSIS 1 0.0002
502 TOOTH INFECTION 3 0.0002
503 PARONYCHIA 1 0.0002
504 INTENTIONAL DEVICE MISUSE 1 0.0002
505 LIGAMENT RUPTURE 1 0.0002
506 VISUAL IMPAIRMENT 28 0.0002
507 BLOOD CREATINE INCREASED 1 0.0002
508 QUALITY OF LIFE DECREASED 3 0.0002
509 SKIN BURNING SENSATION 16 0.0002
510 IRON DEFICIENCY 1 0.0002
511 OROPHARYNGEAL DISCOMFORT 2 0.0002
512 LIMB INJURY 6 0.0002
513 GINGIVAL BLEEDING 3 0.0002
514 LOSS OF CONSCIOUSNESS 28 0.0002
515 EAR DISORDER 1 0.0002
516 PAIN 134 0.0002
517 INCREASED TENDENCY TO BRUISE 2 0.0002
518 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
519 BACTERIAL INFECTION 4 0.0002
520 SQUAMOUS CELL CARCINOMA 2 0.0002
521 COLITIS MICROSCOPIC 1 0.0002
522 ACNE 16 0.0002
523 GESTATIONAL DIABETES 1 0.0002
524 EYE PRURITUS 7 0.0002
525 HYPERCHOLESTEROLAEMIA 2 0.0002
526 JOINT SWELLING 25 0.0002
527 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
528 PHARYNGEAL SWELLING 2 0.0002
529 MUCOUS STOOLS 1 0.0002
530 SKIN EXFOLIATION 17 0.0002
531 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
532 KLEBSIELLA INFECTION 1 0.0002
533 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
534 EYELID PTOSIS 2 0.0002
535 DISCOMFORT 12 0.0002
536 INITIAL INSOMNIA 2 0.0002
537 POOR VENOUS ACCESS 2 0.0002
538 BASAL CELL CARCINOMA 3 0.0002
539 TRANSFUSION 2 0.0002
540 PRODUCT USE COMPLAINT 3 0.0002
541 ANORECTAL DISCOMFORT 1 0.0002
542 ABSCESS 3 0.0002
543 JOINT INJURY 4 0.0002
544 FOOD POISONING 1 0.0002
545 INFECTION 27 0.0002
546 OVERWEIGHT 1 0.0002
547 THROAT TIGHTNESS 5 0.0002
548 ABDOMINAL DISCOMFORT 31 0.0002
549 BLOOD POTASSIUM INCREASED 3 0.0002
550 CONSTIPATION 40 0.0002
551 JAW DISORDER 1 0.0002
552 PROSTATIC DISORDER 1 0.0002
553 MALNUTRITION 2 0.0002
554 EYE INFECTION 2 0.0002
555 PREMATURE LABOUR 1 0.0002
556 PERONEAL NERVE PALSY 1 0.0002
557 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
558 DYSGEUSIA 13 0.0002
559 DRY MOUTH 14 0.0002
560 PRODUCT STORAGE ERROR 15 0.0002
561 INTENTIONAL PRODUCT MISUSE 15 0.0002
562 ENERGY INCREASED 1 0.0002
563 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
564 CARDIAC PACEMAKER INSERTION 1 0.0002
565 HYPERLIPIDAEMIA 2 0.0002
566 PROTHROMBIN TIME PROLONGED 1 0.0002
567 GAIT DISTURBANCE 32 0.0002
568 HEARING IMPAIRED 1 0.0002
569 BLOOD PRESSURE FLUCTUATION 4 0.0002
570 APHASIA 5 0.0002
571 HAEMORRHAGE 17 0.0002
572 PIGMENTATION DISORDER 1 0.0002
573 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
574 TOOTH EXTRACTION 2 0.0002
575 INFUSION SITE EXTRAVASATION 1 0.0002
576 NASAL DRYNESS 1 0.0002
577 MULTIPLE INJURIES 1 0.0002
578 FOREIGN BODY SENSATION IN EYES 1 0.0002
579 THROAT IRRITATION 7 0.0002
580 HAEMOGLOBIN ABNORMAL 1 0.0002
581 RASH GENERALISED 4 0.0002
582 PULMONARY CONGESTION 2 0.0002
583 SINUS DISORDER 3 0.0002
584 CORONAVIRUS INFECTION 1 0.0002
585 FUNGAL INFECTION 5 0.0001
586 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
587 SPINAL FRACTURE 3 0.0001
588 CHOLECYSTITIS CHRONIC 1 0.0001
589 BREAST MASS 1 0.0001
590 FEAR 4 0.0001
591 SINUS CONGESTION 2 0.0001
592 MYALGIA 25 0.0001
593 BODY TEMPERATURE INCREASED 3 0.0001
594 SKIN LESION 4 0.0001
595 ONYCHOCLASIS 1 0.0001
596 RESPIRATION ABNORMAL 1 0.0001
597 JOINT EFFUSION 1 0.0001
598 FORMICATION 1 0.0001
599 DEVICE OCCLUSION 2 0.0001
600 SKIN REACTION 2 0.0001
601 PAPULE 1 0.0001
602 GRAFT VERSUS HOST DISEASE 1 0.0001
603 CELLULITIS 7 0.0001
604 PANIC REACTION 1 0.0001
605 PRODUCT DISPENSING ERROR 3 0.0001
606 BACK PAIN 32 0.0001
607 RASH PUSTULAR 1 0.0001
608 DIZZINESS 68 0.0001
609 ASCITES 4 0.0001
610 BLINDNESS TRANSIENT 1 0.0001
611 PSYCHIATRIC SYMPTOM 1 0.0001
612 ARTHROPOD BITE 1 0.0001
613 FEELING DRUNK 1 0.0001
614 HEADACHE 84 0.0001
615 RASH PAPULAR 3 0.0001
616 GENERAL SYMPTOM 1 0.0001
617 LACRIMATION INCREASED 4 0.0001
618 ECONOMIC PROBLEM 2 0.0001
619 OSTEOPENIA 2 0.0001
620 OFF LABEL USE 115 0.0001
621 HYPERTHERMIA 1 0.0001
622 INSURANCE ISSUE 2 0.0001
623 FOOD ALLERGY 1 0.0001
624 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
625 SINUSITIS 13 0.0001
626 HAEMOGLOBIN DECREASED 13 0.0001
627 ULCER 2 0.0001
628 WEIGHT DECREASED 35 0.0001
629 HYPOTHYROIDISM 4 0.0001
630 ABDOMINAL PAIN 29 0.0001
631 LOCALISED INFECTION 3 0.0001
632 BACK DISORDER 2 0.0001
633 POST PROCEDURAL INFECTION 1 0.0001
634 DECUBITUS ULCER 1 0.0001
635 INJECTION SITE URTICARIA 3 0.0001
636 VIRAL INFECTION 4 0.0001
637 LIVE BIRTH 1 0.0001
638 INFLAMMATION 6 0.0001
639 MUSCULOSKELETAL DISCOMFORT 2 0.0001
640 MUSCLE STRAIN 1 0.0001
641 CARDIAC MURMUR 1 0.0001
642 PYELONEPHRITIS 1 0.0001
643 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
644 JOINT STIFFNESS 3 0.0001
645 ASTHENIA 43 0.0001
646 FEELING HOT 7 0.0001
647 ANHEDONIA 3 0.0001
648 HEAD DISCOMFORT 2 0.0001
649 EAR INFECTION 3 0.0001
650 RESPIRATORY RATE INCREASED 1 0.0001
651 THIRST 2 0.0001
652 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
653 GOUT 2 0.0001
654 THERAPY NON-RESPONDER 5 0.0001
655 GASTROENTERITIS VIRAL 2 0.0001
656 OSTEOMYELITIS 2 0.0001
657 PNEUMONIA BACTERIAL 1 0.0001
658 FEELING ABNORMAL 26 0.0001
659 NERVE COMPRESSION 1 0.0001
660 PRODUCT DISTRIBUTION ISSUE 1 0.0001
661 DYSPNOEA 61 0.0001
662 FEELING COLD 3 0.0001
663 ERYTHEMA MULTIFORME 1 0.0001
664 NEPHROPATHY 1 0.0001
665 DEFORMITY 1 0.0001
666 FLANK PAIN 1 0.0001
667 VOMITING 50 0.0001
668 FOOT FRACTURE 2 0.0001
669 DISEASE RECURRENCE 5 0.0001
670 RECALLED PRODUCT ADMINISTERED 1 0.0001
671 EYE INFLAMMATION 1 0.0001
672 SLEEP APNOEA SYNDROME 2 0.0001
673 RASH ERYTHEMATOUS 5 0.0001
674 ATELECTASIS 1 0.0001
675 DIZZINESS POSTURAL 1 0.0001
676 HEPATOMEGALY 1 0.0001
677 LIGAMENT SPRAIN 1 0.0001
678 BLADDER DISORDER 1 0.0001
679 PRODUCT PHYSICAL ISSUE 2 0.0001
680 EXTRA DOSE ADMINISTERED 4 0.0001
681 DRY THROAT 1 0.0001
682 NASOPHARYNGITIS 18 0.0001
683 EAR DISCOMFORT 1 0.0001
684 HELICOBACTER INFECTION 1 0.0001
685 OROPHARYNGEAL PAIN 9 0.0001
686 PETECHIAE 1 0.0001
687 INJECTION SITE DISCOMFORT 1 0.0001
688 FULL BLOOD COUNT ABNORMAL 1 0.0001
689 CYSTITIS 3 0.0001
690 IMPAIRED WORK ABILITY 2 0.0001
691 BODY HEIGHT DECREASED 1 0.0001
692 IRRITABLE BOWEL SYNDROME 2 0.0001
693 DIARRHOEA 59 0.0001
694 EYE DISORDER 3 0.0001
695 DENTAL CARIES 1 0.0001
696 OXYGEN SATURATION DECREASED 5 0.0001
697 BLOOD CALCIUM DECREASED 1 0.0001
698 CHROMATURIA 2 0.0001
699 REBOUND EFFECT 1 0.0001
700 INCORRECT DOSE ADMINISTERED 20 0.0001
701 MICTURITION URGENCY 1 0.0001
702 CHOLECYSTECTOMY 1 0.0001
703 GASTRIC DISORDER 3 0.0001
704 ILLNESS 9 0.0001
705 NEPHROLITHIASIS 4 0.0001
706 ARTHRALGIA 36 0.0001
707 MADAROSIS 1 0.0001
708 EYELID OEDEMA 1 0.0001
709 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
710 DYSPHONIA 5 0.0001
711 PALPITATIONS 10 0.0001
712 COVID-19 PNEUMONIA 1 0.0001
713 BACTERAEMIA 1 0.0001
714 PRODUCT PRESCRIBING ERROR 2 0.0001
715 CHOLECYSTITIS 1 0.0001
716 THERAPEUTIC RESPONSE DECREASED 5 0.0001
717 BURSITIS 1 0.0001
718 NOCTURIA 1 0.0001
719 NO THERAPEUTIC RESPONSE 1 0.0001
720 INJECTION SITE MASS 3 0.0001
721 PHARYNGITIS 1 0.0001
722 CYST 1 0.0001
723 ILEUS 1 0.0001
724 HAIR COLOUR CHANGES 1 0.0001
725 AGEUSIA 2 0.0001
726 POISONING 1 0.0001
727 MUSCLE ATROPHY 1 0.0001
728 FATIGUE 61 0.0001
729 ROTATOR CUFF SYNDROME 1 0.0001
730 ANOREXIA 1 0.0001
731 RESPIRATORY TRACT INFECTION 2 0.0001
732 NODULE 1 0.0001
733 NERVOUSNESS 4 0.0001
734 MUCOSAL INFLAMMATION 2 0.0001
735 IMMUNE SYSTEM DISORDER 1 0.0001
736 PYREXIA 26 0.0001
737 EYE HAEMORRHAGE 1 0.0001
738 JOINT RANGE OF MOTION DECREASED 1 0.0001
739 PAIN OF SKIN 2 0.0001
740 PRODUCT TASTE ABNORMAL 1 0.0001
741 ANXIETY 21 0.0001
742 IMPAIRED GASTRIC EMPTYING 1 0.0001
743 MIGRAINE 7 0.0001
744 NAUSEA 58 0.0001
745 TREATMENT NONCOMPLIANCE 4 0.0001
746 PERIPHERAL COLDNESS 1 0.0001
747 CARPAL TUNNEL SYNDROME 1 0.0001
748 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
749 HYPERTHYROIDISM 1 0.0001
750 SEPTIC SHOCK 3 0.0001
751 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
752 LIVER FUNCTION TEST ABNORMAL 2 0.0001
753 FLUID OVERLOAD 1 0.0001
754 DYSSTASIA 2 0.0001
755 UNDERDOSE 5 0.0001
756 LIVER DISORDER 3 0.0001
757 DEHYDRATION 9 0.0001
758 IMMUNODEFICIENCY 1 0.0001
759 IRRITABILITY 4 0.0001
760 BLOOD POTASSIUM DECREASED 2 0.0001
761 UNEVALUABLE EVENT 5 0.0001
762 VERTIGO 4 0.0001
763 HIP ARTHROPLASTY 1 0.0001
764 INJECTION SITE SWELLING 5 0.0001
765 PERIPHERAL SWELLING 10 0.0001
766 EMOTIONAL DISORDER 2 0.0001
767 LYMPHOMA 1 0.0001
768 MUSCULOSKELETAL CHEST PAIN 1 0.0001
769 BLOOD CHOLESTEROL INCREASED 3 0.0001
770 ARRHYTHMIA 3 0.0001
771 RESPIRATORY TRACT CONGESTION 1 0.0001
772 HALLUCINATION, AUDITORY 1 0.0001
773 PRODUCTIVE COUGH 3 0.0001
774 MOVEMENT DISORDER 2 0.0001
775 NIGHT SWEATS 2 0.0001
776 ASTHMA 7 0.0001
777 DEEP VEIN THROMBOSIS 4 0.0001
778 LUNG DISORDER 3 0.0001
779 METASTASES TO BONE 1 0.0001
780 PHOTOSENSITIVITY REACTION 1 0.0001
781 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
782 BLOOD PRESSURE DECREASED 4 0.0001
783 INSOMNIA 16 0.0001
784 URINARY RETENTION 2 0.0001
785 GAIT INABILITY 2 0.0001
786 INJECTION SITE PRURITUS 4 0.0001
787 RENAL IMPAIRMENT 5 0.0001
788 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
789 CANDIDA INFECTION 1 0.0001
790 HEMIPARESIS 1 0.0001
791 VISION BLURRED 8 0.0001
792 EMOTIONAL DISTRESS 7 0.0001
793 DEVICE USE ISSUE 1 0.0001
794 MALAISE 25 0.0001
795 HEART RATE DECREASED 2 0.0001
796 INJURY 4 0.0001
797 DEPRESSED MOOD 3 0.0001
798 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
799 DRUG ERUPTION 1 0.0001
800 NO ADVERSE EVENT 10 0.0001
801 BONE DISORDER 1 0.0001
802 END STAGE RENAL DISEASE 1 0.0001
803 MUSCLE SPASMS 10 0.0001
804 CHEST PAIN 10 0.0001
805 CONJUNCTIVITIS 1 0.0001
806 HEPATIC STEATOSIS 1 0.0001
807 PANCYTOPENIA 3 0.0001
808 MIDDLE INSOMNIA 1 0.0001
809 COUGH 15 0.0001
810 URINARY TRACT INFECTION 9 0.0001
811 FEELING JITTERY 1 0.0001
812 INCREASED APPETITE 1 0.0001
813 ACUTE RESPIRATORY FAILURE 1 0.0001
814 ERUCTATION 1 0.0001
815 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
816 HAEMORRHOIDS 1 0.0001
817 NASAL CONGESTION 3 0.0001
818 KIDNEY INFECTION 1 0.0001
819 ARTHRITIS 4 0.0001
820 DISABILITY 1 0.0001
821 HEART RATE INCREASED 5 0.0001
822 HAEMATOCRIT DECREASED 1 0.0001
823 BLOOD PRESSURE ABNORMAL 1 0.0001
824 FULL BLOOD COUNT DECREASED 1 0.0000
825 DYSKINESIA 2 0.0000
826 INJURY ASSOCIATED WITH DEVICE 1 0.0000
827 BLINDNESS 2 0.0000
828 PRODUCT PREPARATION ERROR 1 0.0000
829 RIB FRACTURE 1 0.0000
830 PERITONITIS 1 0.0000
831 TREMOR 8 0.0000
832 PULMONARY HYPERTENSION 1 0.0000
833 POLLAKIURIA 2 0.0000
834 RETCHING 1 0.0000
835 RECTAL HAEMORRHAGE 2 0.0000
836 AMNESIA 3 0.0000
837 VAGINAL HAEMORRHAGE 2 0.0000
838 DEVICE DISLOCATION 2 0.0000
839 MENTAL DISORDER 2 0.0000
840 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
841 DEVICE DIFFICULT TO USE 3 0.0000
842 FEBRILE NEUTROPENIA 3 0.0000
843 TACHYCARDIA 4 0.0000
844 COLITIS ULCERATIVE 2 0.0000
845 GASTROINTESTINAL DISORDER 4 0.0000
846 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
847 PRODUCT AVAILABILITY ISSUE 1 0.0000
848 MUSCLE TWITCHING 1 0.0000
849 SEIZURE 5 0.0000
850 PERICARDIAL EFFUSION 1 0.0000
851 COGNITIVE DISORDER 2 0.0000
852 CEREBROVASCULAR ACCIDENT 7 0.0000
853 MENTAL IMPAIRMENT 1 0.0000
854 RESPIRATORY FAILURE 3 0.0000
855 NEURALGIA 1 0.0000
856 OEDEMA PERIPHERAL 5 0.0000
857 AGITATION 3 0.0000
858 LIVER INJURY 1 0.0000
859 BRONCHITIS 3 0.0000
860 INJECTION SITE ERYTHEMA 5 0.0000
861 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
862 DRY EYE 2 0.0000
863 PNEUMONIA ASPIRATION 1 0.0000
864 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
865 CHRONIC KIDNEY DISEASE 3 0.0000
866 FLUID RETENTION 2 0.0000
867 HYPOPHAGIA 1 0.0000
868 DRUG RESISTANCE 1 0.0000
869 ANAPHYLACTIC SHOCK 1 0.0000
870 EXPOSURE VIA SKIN CONTACT 1 0.0000
871 DIPLOPIA 1 0.0000
872 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
873 HYPERTENSION 8 0.0000
874 INJECTION SITE HAEMORRHAGE 3 0.0000
875 PAIN IN EXTREMITY 11 0.0000
876 THROMBOSIS 3 0.0000
877 FREQUENT BOWEL MOVEMENTS 1 0.0000
878 RASH PRURITIC 2 0.0000
879 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
880 INFLUENZA LIKE ILLNESS 3 0.0000
881 DRUG DOSE OMISSION 6 0.0000
882 DIVERTICULITIS 1 0.0000
883 MENTAL STATUS CHANGES 1 0.0000
884 INJECTION SITE PAIN 11 0.0000
885 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
886 MUSCULAR WEAKNESS 4 0.0000
887 INTENTIONAL DOSE OMISSION 1 0.0000
888 HERPES ZOSTER 2 0.0000
889 LETHARGY 2 0.0000
890 PRODUCT SUBSTITUTION ISSUE 2 0.0000
891 DECREASED APPETITE 8 0.0000
892 COVID-19 6 0.0000
893 BONE PAIN 2 0.0000
894 PSYCHOTIC DISORDER 1 0.0000
895 DISEASE PROGRESSION 4 0.0000
896 CATARACT 2 0.0000
897 DEVICE ISSUE 3 0.0000
898 HEPATIC FAILURE 1 0.0000
899 PLEURAL EFFUSION 2 0.0000
900 SUICIDAL IDEATION 3 0.0000
901 LIMB DISCOMFORT 1 0.0000
902 FEMUR FRACTURE 1 0.0000
903 NERVOUS SYSTEM DISORDER 1 0.0000
904 BONE DENSITY DECREASED 1 0.0000
905 PULMONARY EMBOLISM 3 0.0000
906 METABOLIC ACIDOSIS 1 0.0000
907 WEIGHT INCREASED 7 0.0000
908 HIP FRACTURE 1 0.0000
909 CONFUSIONAL STATE 5 0.0000
910 PNEUMONIA 10 0.0000
911 DEPRESSION 7 0.0000
912 PSORIASIS 4 0.0000
913 CHOLELITHIASIS 1 0.0000
914 DYSPEPSIA 3 0.0000
915 RENAL FAILURE 4 0.0000
916 NEOPLASM MALIGNANT 2 0.0000
917 ANGER 1 0.0000
918 FLUSHING 3 0.0000
919 HAEMATURIA 1 0.0000
920 ABDOMINAL PAIN UPPER 6 0.0000
921 INJECTION SITE REACTION 2 0.0000
922 NIGHTMARE 1 0.0000
923 DEVICE USE ERROR 1 0.0000
924 NEOPLASM PROGRESSION 1 0.0000
925 ABDOMINAL DISTENSION 3 0.0000
926 HYPOXIA 1 0.0000
927 SLEEP DISORDER 2 0.0000
928 CEREBRAL HAEMORRHAGE 1 0.0000
929 MOBILITY DECREASED 2 0.0000
930 PANIC ATTACK 1 0.0000
931 DYSURIA 1 0.0000
932 FALL 9 0.0000
933 INFLUENZA 3 0.0000
934 SEPSIS 3 0.0000
935 EPISTAXIS 2 0.0000
936 DYSARTHRIA 1 0.0000
937 DYSPNOEA EXERTIONAL 1 0.0000
938 HOT FLUSH 2 0.0000
939 HOSPITALISATION 4 0.0000
940 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
941 ABNORMAL BEHAVIOUR 1 0.0000
942 CARDIAC FAILURE CONGESTIVE 2 0.0000
943 DRUG DEPENDENCE 4 0.0000
944 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
945 PSORIATIC ARTHROPATHY 1 0.0000
946 OSTEOPOROSIS 1 0.0000
947 ROAD TRAFFIC ACCIDENT 1 0.0000
948 PRODUCT DOSE OMISSION ISSUE 7 0.0000
949 OVERDOSE 5 0.0000
950 BALANCE DISORDER 2 0.0000
951 ANGIOEDEMA 1 0.0000
952 PULMONARY OEDEMA 1 0.0000
953 HYPOKALAEMIA 1 0.0000
954 BLOOD GLUCOSE INCREASED 4 0.0000
955 NEUROPATHY PERIPHERAL 2 0.0000
956 COMA 1 0.0000
957 MULTIPLE SCLEROSIS 1 0.0000
958 BLOOD GLUCOSE DECREASED 1 0.0000
959 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
960 HYPOGLYCAEMIA 1 0.0000
961 HYPOTENSION 4 0.0000
962 BLOOD PRESSURE INCREASED 3 0.0000
963 ECZEMA 1 0.0000
964 PLATELET COUNT DECREASED 2 0.0000
965 HAEMATOCHEZIA 1 0.0000
966 ARTHROPATHY 1 0.0000
967 FLATULENCE 1 0.0000
968 CONVULSION 1 0.0000
969 INTENTIONAL OVERDOSE 1 0.0000
970 ALOPECIA 3 0.0000
971 INFUSION RELATED REACTION 1 0.0000
972 SOMNOLENCE 3 0.0000
973 NEUTROPENIA 2 0.0000
974 MEMORY IMPAIRMENT 2 0.0000
975 DEVICE MALFUNCTION 1 0.0000
976 DIABETES MELLITUS 1 0.0000
977 ACUTE KIDNEY INJURY 2 0.0000
978 DRUG INTERACTION 2 0.0000
979 INJECTION SITE BRUISING 1 0.0000
980 CARDIAC FAILURE 1 0.0000
981 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
982 DRUG ABUSE 1 0.0000
983 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
984 DRUG WITHDRAWAL SYNDROME 1 0.0000
985 BREAST CANCER 1 0.0000
986 CARDIAC DISORDER 1 0.0000
987 ANAEMIA 2 0.0000
988 ATRIAL FIBRILLATION 1 0.0000
989 CHEST DISCOMFORT 1 0.0000
990 DEATH 6 0.0000
991 MYOCARDIAL INFARCTION 1 0.0000